Stay updated on Venetoclax Combo vs Azacitidine in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Combo vs Azacitidine in AML Clinical Trial page.

Latest updates to the Venetoclax Combo vs Azacitidine in AML Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3. This reflects an updated release/version of the page documentation.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedFooter now shows Revision: v3.6.3, replacing Revision: v3.6.0, indicating a newer site release without altering the study information.SummaryDifference0.0%

- Check43 days agoChange DetectedThe study page now shows recruitment status updates (Active, not recruiting; No longer looking for participants) and adds new guidance/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) with an estimated timeline and a page Revision: v3.6.0; older labels such as Completed and Actual were removed.SummaryDifference0.4%

- Check50 days agoChange DetectedThe page now shows Revision: v3.5.5, replacing the previous v3.5.4, indicating a minor build update. This change does not modify the page content or user-facing features.SummaryDifference0.0%

- Check72 days agoChange DetectedThe study status changed from Active, not recruiting to Completed, with a new revision (v3.5.4) and the latest update posted on 2026-05-15; the record also notes an actual completion date of 2025-11-24.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page’s footer/site “Revision” label was updated from v3.5.2 to v3.5.3, indicating a new release of the page system without changing the listed clinical trial details.SummaryDifference0.0%

Stay in the know with updates to Venetoclax Combo vs Azacitidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo vs Azacitidine in AML Clinical Trial page.